Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
IDEXX Laboratories, Inc. (IDXX) had Consolidated Net Income/Loss of $248.19M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.09B |
|
$248.19M |
|
$432.47M |
|
$658.11M |
|
$774.97M |
|
$315.61M |
|
$-8.62M |
|
$306.98M |
|
$306.98M |
|
$248.19M |
|
$248.19M |
|
|
Consolidated Net Income/Loss |
$248.19M |
$248.19M |
|
$315.61M |
|
$354.33M |
|
80.43M |
|
81.03M |
|
$3.10 |
|
$3.09 |
|
| Balance Sheet Financials | |
$1.41B |
|
$747.38M |
|
$1.94B |
|
$3.35B |
|
$1.15B |
|
$374.84M |
|
$596.56M |
|
$1.75B |
|
$1.61B |
|
$1.08B |
|
$1.61B |
|
79.71M |
|
| Cash Flow Statement Financials | |
$1.18B |
|
$-136.24M |
|
$-1.16B |
|
$288.27M |
|
$180.07M |
|
$-108.20M |
|
$60.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.23 |
|
-- |
|
-- |
|
0.19 |
|
0.53 |
|
60.35% |
|
28.94% |
|
28.94% |
|
-- |
|
28.15% |
|
22.76% |
|
$1.06B |
|
-- |
|
-- |
|
-- |
|
0.33 |
|
1.14 |
|
1.97 |
|
45.59 |
|
15.46% |
|
22.95% |
|
7.41% |
|
12.53% |
|
$20.14 |
|
$13.05 |
|
$14.59 |
|